BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22537906)

  • 1. Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer.
    Zhou Z; Chen ZW; Yang XH; Shen L; Ai XH; Lu S; Luo QQ
    J Exp Clin Cancer Res; 2012 Apr; 31(1):34. PubMed ID: 22537906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
    Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
    Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
    Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
    BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
    Yao NS; Wu YY; Janckila AJ; Ku CH; Hsieh AT; Ho CL; Lee SH; Chao TY
    Clin Chim Acta; 2011 Jan; 412(1-2):181-5. PubMed ID: 20932965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study.
    Guo X; Li M; Wang X; Pan Y; Li J
    BMC Pulm Med; 2021 Apr; 21(1):111. PubMed ID: 33794845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.
    Gomez-Roca C; Raynaud CM; Penault-Llorca F; Mercier O; Commo F; Morat L; Sabatier L; Dartevelle P; Taranchon E; Besse B; Validire P; Italiano A; Soria JC
    J Thorac Oncol; 2009 Oct; 4(10):1212-20. PubMed ID: 19687761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a serological molecular model for the early diagnosis and progression monitoring of bone metastasis in lung cancer.
    Teng X; Wei L; Han L; Min D; Du Y
    BMC Cancer; 2020 Jun; 20(1):562. PubMed ID: 32546271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for bone metastasis in completely resected non-small-cell lung cancer.
    Wang H; Zhang Y; Zhu H; Yu J
    Future Oncol; 2017 Apr; 13(8):695-704. PubMed ID: 27866423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].
    Yao Y; Zhou Y; Yang Z; Shen H
    Zhongguo Fei Ai Za Zhi; 2018 Jun; 21(6):476-480. PubMed ID: 29945707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cell free DNA as a prognostic biomarker in non-small cell lung cancer patients with bone metastasis.
    Ye Y; Luo Z; Shi D
    Int J Biol Markers; 2019 Dec; 34(4):381-388. PubMed ID: 31218912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.
    Spano JP; Andre F; Morat L; Sabatier L; Besse B; Combadiere C; Deterre P; Martin A; Azorin J; Valeyre D; Khayat D; Le Chevalier T; Soria JC
    Ann Oncol; 2004 Apr; 15(4):613-7. PubMed ID: 15033669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapulmonary metastasis in resected pathologic stage IIIB non-small cell lung cancer: possible contribution of aerogenous metastasis to the favorable outcome.
    Aokage K; Ishii G; Nagai K; Kawai O; Naito Y; Hasebe T; Nishimura M; Yoshida J; Ochiai A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):386-91. PubMed ID: 17662777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin αvβ5 as a biomarker for the assessment of non-small cell lung cancer metastasis and overall survival.
    Bai SY; Xu N; Chen C; Song YL; Hu J; Bai CX
    Clin Respir J; 2015 Oct; 9(4):457-67. PubMed ID: 24815623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.
    Liu B; Wan Z; Sheng B; Lin Y; Fu T; Zeng Q; Qi C
    BMC Pulm Med; 2017 Dec; 17(1):214. PubMed ID: 29282042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer.
    He JJ; Zhi K; Liu GF
    Onkologie; 2011; 34(11):584-8. PubMed ID: 22104154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.